Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic applications of CRISPR/Cas9 gene editing technology for the treatment of ocular diseases.
FEBS J. 2023 Nov;290(22):5248-5269. doi: 10.1111/febs.16771. Epub 2023 Mar 27.
FEBS J. 2023.
PMID: 36877952
Review.
Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma.
Patil SV, Kaipa BR, Ranshing S, Sundaresan Y, Millar JC, Nagarajan B, Kiehlbauch C, Zhang Q, Jain A, Searby CC, Scheetz TE, Clark AF, Sheffield VC, Zode GS.
Patil SV, et al.
Sci Rep. 2024 Mar 23;14(1):6958. doi: 10.1038/s41598-024-57286-6.
Sci Rep. 2024.
PMID: 38521856
Free PMC article.
Item in Clipboard
Modulation of Mitochondrial Metabolic Parameters and Antioxidant Enzymes in Healthy and Glaucomatous Trabecular Meshwork Cells with Hybrid Small Molecule SA-2.
Amankwa CE, Young O, DebNath B, Gondi SR, Rangan R, Ellis DZ, Zode G, Stankowska DL, Acharya S.
Amankwa CE, et al.
Int J Mol Sci. 2023 Jul 17;24(14):11557. doi: 10.3390/ijms241411557.
Int J Mol Sci. 2023.
PMID: 37511316
Free PMC article.
Item in Clipboard
Cite
Cite